Cargando…
Oral Nystatin Versus Intravenous Fluconazole as Neonatal Antifungal Prophylaxis: Non-inferiority Trial
BACKGROUND: Fluconazole has shown to be effective in reducing both colonization and invasive Candida infection (ICI) in ELBW neonates; we conducted a randomized trial to compare oral nystatin with intravenous fluconazole for prophylaxis against invasive Candidiasis in high risk neonates. MATERIALS A...
Autores principales: | Mersal, Ali, Alzahrani, Ibrahim, Azzouz, Mahasen, Alsubhi, Adel, Alsawaigh, Heba, Albshri, Nouf, Bajammal, Manal, Avand, Ghazal, Almahbosh, Abdulmajid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775143/ https://www.ncbi.nlm.nih.gov/pubmed/24049751 http://dx.doi.org/10.4103/2249-4847.116408 |
Ejemplares similares
-
Antifungal effect of Atorvastatin against Candida species in comparison to Fluconazole and Nystatin
por: Esfahani, Ava Nasr, et al.
Publicado: (2019) -
Preparation, characterization and properties of three different nanomaterials either alone or loaded with nystatin or fluconazole antifungals
por: Helal, Sara H., et al.
Publicado: (2022) -
Antifungal Susceptibility of Oral Candida Isolates from Mother-Infant Dyads to Nystatin, Fluconazole, and Caspofungin
por: Alkhars, Naemah, et al.
Publicado: (2023) -
Antifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropenia
por: Döring, M., et al.
Publicado: (2015) -
Antifungal Activity of ZnO Nanoparticles and Nystatin and Downregulation of SAP1-3 Genes Expression in Fluconazole-Resistant Candida albicans Isolates from Vulvovaginal Candidiasis
por: Hosseini, Seyededeh Sedigheh, et al.
Publicado: (2020)